These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 31200637)
1. ERK1/2 communicates GPCR and EGFR signaling pathways to promote CTGF-mediated hypertrophic cardiomyopathy upon Ang-II stimulation. Liu X; Lin L; Li Q; Ni Y; Zhang C; Qin S; Wei J BMC Mol Cell Biol; 2019 Jun; 20(1):14. PubMed ID: 31200637 [TBL] [Abstract][Full Text] [Related]
2. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation. Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040 [TBL] [Abstract][Full Text] [Related]
4. Endogenous endothelin 1 mediates angiotensin II-induced hypertrophy in electrically paced cardiac myocytes through EGFR transactivation, reactive oxygen species and NHE-1. Correa MV; Nolly MB; Caldiz CI; de Cingolani GE; Cingolani HE; Ennis IL Pflugers Arch; 2014 Sep; 466(9):1819-30. PubMed ID: 24327206 [TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis. Wong CKS; Falkenham A; Myers T; Légaré JF J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318759358. PubMed ID: 29575960 [TBL] [Abstract][Full Text] [Related]
6. Death receptor 5 contributes to cardiomyocyte hypertrophy through epidermal growth factor receptor transactivation. Tanner MA; Thomas TP; Grisanti LA J Mol Cell Cardiol; 2019 Nov; 136():1-14. PubMed ID: 31473246 [TBL] [Abstract][Full Text] [Related]
7. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling. Ai W; Zhang Y; Tang QZ; Yan L; Bian ZY; Liu C; Huang H; Bai X; Yin L; Li H J Cell Biochem; 2010 Aug; 110(5):1111-22. PubMed ID: 20564207 [TBL] [Abstract][Full Text] [Related]
8. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1. Rajapurohitam V; Javadov S; Purdham DM; Kirshenbaum LA; Karmazyn M J Mol Cell Cardiol; 2006 Aug; 41(2):265-74. PubMed ID: 16806260 [TBL] [Abstract][Full Text] [Related]
9. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth. Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416 [TBL] [Abstract][Full Text] [Related]
10. Connective tissue growth factor induces cardiac hypertrophy through Akt signaling. Hayata N; Fujio Y; Yamamoto Y; Iwakura T; Obana M; Takai M; Mohri T; Nonen S; Maeda M; Azuma J Biochem Biophys Res Commun; 2008 May; 370(2):274-8. PubMed ID: 18375200 [TBL] [Abstract][Full Text] [Related]
11. sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation. Lim S; Lee ME; Jeong J; Lee J; Cho S; Seo M; Park S Inflamm Res; 2018 Aug; 67(8):691-701. PubMed ID: 29796842 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3. Yang F; Chung AC; Huang XR; Lan HY Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256 [TBL] [Abstract][Full Text] [Related]
13. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes. Ko WC; Hong CY; Hou SM; Lin CH; Ong ET; Lee CF; Tsai CT; Lai LP Circ J; 2011; 75(7):1592-600. PubMed ID: 21576830 [TBL] [Abstract][Full Text] [Related]
14. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Thomas WG; Brandenburger Y; Autelitano DJ; Pham T; Qian H; Hannan RD Circ Res; 2002 Feb; 90(2):135-42. PubMed ID: 11834705 [TBL] [Abstract][Full Text] [Related]
15. Gallic Acid Suppresses Cardiac Hypertrophic Remodeling and Heart Failure. Yan X; Zhang YL; Zhang L; Zou LX; Chen C; Liu Y; Xia YL; Li HH Mol Nutr Food Res; 2019 Mar; 63(5):e1800807. PubMed ID: 30521107 [TBL] [Abstract][Full Text] [Related]
16. Interactions between the ERK1/2 signaling pathway and PCAF play a key role in PE‑induced cardiomyocyte hypertrophy. Mao Q; Wu S; Peng C; Peng B; Luo X; Huang L; Zhang H Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278478 [TBL] [Abstract][Full Text] [Related]
17. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice. Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521 [TBL] [Abstract][Full Text] [Related]
18. Different contributions of STAT3, ERK1/2, and PI3-K signaling to cardiomyocyte hypertrophy by cardiotrophin-1. Tian ZJ; Cui W; Li YJ; Hao YM; Du J; Liu F; Zhang H; Zu XG; Liu SY; Chen L; An W Acta Pharmacol Sin; 2004 Sep; 25(9):1157-64. PubMed ID: 15339391 [TBL] [Abstract][Full Text] [Related]